EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 93 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $2,428,000 | -31.4% | 284,988 | -28.8% | 0.08% | +3.8% |
| Q1 2021 | $3,540,000 | -28.0% | 400,000 | 0.0% | 0.08% | -32.5% |
| Q4 2020 | $4,916,000 | +34.4% | 400,000 | -11.0% | 0.12% | -17.0% |
| Q3 2020 | $3,659,000 | -45.6% | 449,510 | -35.8% | 0.14% | -44.9% |
| Q2 2020 | $6,720,000 | +21.2% | 700,000 | -14.1% | 0.26% | -0.8% |
| Q1 2020 | $5,543,000 | -55.4% | 815,127 | -2.2% | 0.26% | -48.0% |
| Q4 2019 | $12,418,000 | +21.4% | 833,400 | -16.5% | 0.50% | -20.4% |
| Q3 2019 | $10,228,000 | -16.1% | 997,892 | -13.2% | 0.62% | -11.0% |
| Q2 2019 | $12,190,000 | – | 1,150,000 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 1,787,091 | $14,118,000 | 3.56% |
| INTERWEST VENTURE MANAGEMENT CO | 1,599,592 | $12,637,000 | 2.99% |
| SPHERA FUNDS MANAGEMENT LTD. | 385,301 | $3,044,000 | 0.52% |
| Boxer Capital, LLC | 138,331 | $1,093,000 | 0.26% |
| DAFNA Capital Management LLC | 35,977 | $284,000 | 0.20% |
| SABBY MANAGEMENT, LLC | 223,100 | $1,762,000 | 0.12% |
| Hikari Power Ltd | 60,992 | $482,000 | 0.06% |
| Perceptive Advisors | 157,679 | $1,245,000 | 0.06% |
| Lombard Odier Asset Management (USA) Corp | 90,000 | $711,000 | 0.06% |
| TFS CAPITAL LLC | 12,128 | $96,000 | 0.04% |